Literature DB >> 18457939

Use of the 15-steps climbing exercise oximetry test in patients with idiopathic pulmonary fibrosis.

Victorya Rusanov1, David Shitrit, Ben Fox, Anat Amital, Nir Peled, Mordechai R Kramer.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is often associated with exercise-induced hypoxemia. Although maximal oxygen consumption (VO2(max)) is considered the gold-standard index of functional capacity in IPF, its measurement requires sophisticated equipment and trained personnel. The aim of the present study was to investigate the value of the simple 15-steps climbing exercise oximetry test in patients with IPF. The 15-steps climbing test was administered to 51 patients with IPF. Pulmonary function tests (PFTs), cardiopulmonary exercise test (CPET), and the 6-min walk distance (6MWD) test were performed in the same session. Oxygen saturation in the 15-steps climbing test was measured by continuous oximetry, and quantified oxygen desaturation was determined by calculating the area under the curve of oxygen saturation from the beginning of exercise through the lowest desaturation point until recovery to baseline ("desaturation area"). There was a statistically significant correlation between all parameters of the 15-steps climbing test and both VO2(max)) on the CPET (lowest saturation, p=0.002, r=0.43; saturation difference, p=0.02, r=-0.33; recovery time, p=0.02, r=-0.32; and desaturation area, p=0.005, r=-0.39), and carbon dioxide diffusion in the lungs (DLCO) on the PFTs (lowest saturation, p=0.0001, r=0.52; saturation difference, p=0.0002, r=-0.50; recovery time, p=0.0001, r=-0.53; and desaturation area, p=0.0001, r=-0.53). On stepwise linear regression analysis, independent significant predictors of VO2(max) were lowest saturation on the 15-steps test and the 6MWD. We concluded that the 15-steps oximetry test is a simple and accurate bedside tool for the evaluation of functional capacity in patients with IPF.

Entities:  

Mesh:

Year:  2008        PMID: 18457939     DOI: 10.1016/j.rmed.2007.12.031

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Step climbing capacity in patients with pulmonary hypertension.

Authors:  Benjamin Daniel Fox; David Langleben; Andrew Hirsch; Kim Boutet; Avi Shimony
Journal:  Clin Res Cardiol       Date:  2012-08-09       Impact factor: 5.460

Review 2.  Performing a lung disability evaluation: how, when, and why?

Authors:  Akshay Sood
Journal:  J Occup Environ Med       Date:  2014-10       Impact factor: 2.162

3.  Step oximetry test: a validation study.

Authors:  Benjamin Daniel Fox; Nadav Sheffy; Baruch Vainshelboim; Leonardo Fuks; Mordechai R Kramer
Journal:  BMJ Open Respir Res       Date:  2018-08-03

4.  Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study.

Authors:  Steve Goodacre; Ben Thomas; Ellen Lee; Laura Sutton; Amanda Loban; Simon Waterhouse; Richard Simmonds; Katie Biggs; Carl Marincowitz; José Schutter; Sarah Connelly; Elena Sheldon; Jamie Hall; Emma Young; Andrew Bentley; Kirsty Challen; Chris Fitzsimmons; Tim Harris; Fiona Lecky; Andrew Lee; Ian Maconochie; Darren Walter
Journal:  Emerg Med J       Date:  2020-12-03       Impact factor: 2.740

5.  Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

Authors:  Sevgi Ozalevli; Hayriye Kul Karaali; Duygu Ilgin; Eyup Sabri Ucan
Journal:  Multidiscip Respir Med       Date:  2010-02-28

Review 6.  Home-based or remote exercise testing in chronic respiratory disease, during the COVID-19 pandemic and beyond: A rapid review.

Authors:  Anne E Holland; Carla Malaguti; Mariana Hoffman; Aroub Lahham; Angela T Burge; Leona Dowman; Anthony K May; Janet Bondarenko; Marnie Graco; Gabriella Tikellis; Joanna Yt Lee; Narelle S Cox
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

7.  IPF patients are limited by mechanical and not pulmonary-vascular factors - results of a derivation-validation cohort study.

Authors:  Benjamin D Fox; Yael Shostak; Barak Pertzov; Baruch Vainshelboim; Shimon Itzhakian; Irit Terner; Mordechai R Kramer
Journal:  BMC Pulm Med       Date:  2019-12-11       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.